These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 20971825)

  • 1. Notch signaling pathway as a therapeutic target in breast cancer.
    Al-Hussaini H; Subramanyam D; Reedijk M; Sridhar SS
    Mol Cancer Ther; 2011 Jan; 10(1):9-15. PubMed ID: 20971825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Notch-out for breast cancer therapies.
    Lamy M; Ferreira A; Dias JS; Braga S; Silva G; Barbas A
    N Biotechnol; 2017 Oct; 39(Pt B):215-221. PubMed ID: 28842360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Notch signaling in breast cancer: From pathway analysis to therapy.
    Krishna BM; Jana S; Singhal J; Horne D; Awasthi S; Salgia R; Singhal SS
    Cancer Lett; 2019 Oct; 461():123-131. PubMed ID: 31326555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Notch signaling and its role in breast cancer.
    Wu F; Stutzman A; Mo YY
    Front Biosci; 2007 May; 12():4370-83. PubMed ID: 17485381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Notch signaling cross-talk with estrogen receptor and ErbB-2 in breast cancer.
    Rizzo P; Osipo C; Pannuti A; Golde T; Osborne B; Miele L
    Adv Enzyme Regul; 2009; 49(1):134-41. PubMed ID: 19344631
    [No Abstract]   [Full Text] [Related]  

  • 6. Notch inhibitors and their role in the treatment of triple negative breast cancer: promises and failures.
    Locatelli M; Curigliano G
    Curr Opin Oncol; 2017 Nov; 29(6):411-427. PubMed ID: 28914645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Notch signaling in breast cancer and tumor angiogenesis: cross-talk and therapeutic potentials.
    Shi W; Harris AL
    J Mammary Gland Biol Neoplasia; 2006 Jan; 11(1):41-52. PubMed ID: 16947085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic targeting of Notch signaling in cancer].
    Brahmi M; Bally O; Eberst L; Cassier P
    Bull Cancer; 2017 Oct; 104(10):883-891. PubMed ID: 29031504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Notch signaling as a therapeutic target for breast cancer treatment?
    Han J; Hendzel MJ; Allalunis-Turner J
    Breast Cancer Res; 2011 May; 13(3):210. PubMed ID: 21672271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study on Notch signaling in human breast cancer.
    Zang S; Ji Ch; Qu X; Dong X; Ma D; Ye J; Ma R; Dai J; Guo D
    Neoplasma; 2007; 54(4):304-10. PubMed ID: 17822320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Notch signaling: an emerging therapeutic target for cancer treatment.
    Yuan X; Wu H; Xu H; Xiong H; Chu Q; Yu S; Wu GS; Wu K
    Cancer Lett; 2015 Dec; 369(1):20-7. PubMed ID: 26341688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting notch signaling pathway in breast cancer stem cells through drug repurposing approach.
    Pathak Y; Camps I; Mishra A; Tripathi V
    Mol Divers; 2023 Dec; 27(6):2431-2440. PubMed ID: 36376717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of Notch pathway by a gamma-secretase inhibitor attenuates AKT/mammalian target of rapamycin signaling and glucose uptake in an ERBB2 transgenic breast cancer model.
    Efferson CL; Winkelmann CT; Ware C; Sullivan T; Giampaoli S; Tammam J; Patel S; Mesiti G; Reilly JF; Gibson RE; Buser C; Yeatman T; Coppola D; Winter C; Clark EA; Draetta GF; Strack PR; Majumder PK
    Cancer Res; 2010 Mar; 70(6):2476-84. PubMed ID: 20197467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent development of targeted approaches for the treatment of breast cancer.
    Maruthanila VL; Elancheran R; Kunnumakkara AB; Kabilan S; Kotoky J
    Breast Cancer; 2017 Mar; 24(2):191-219. PubMed ID: 27796923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Notch signaling and breast cancer.
    Reedijk M
    Adv Exp Med Biol; 2012; 727():241-57. PubMed ID: 22399352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NOTCH signaling as a novel cancer therapeutic target.
    Miele L; Miao H; Nickoloff BJ
    Curr Cancer Drug Targets; 2006 Jun; 6(4):313-23. PubMed ID: 16848722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NOTCH3 signaling pathway plays crucial roles in the proliferation of ErbB2-negative human breast cancer cells.
    Yamaguchi N; Oyama T; Ito E; Satoh H; Azuma S; Hayashi M; Shimizu K; Honma R; Yanagisawa Y; Nishikawa A; Kawamura M; Imai J; Ohwada S; Tatsuta K; Inoue J; Semba K; Watanabe S
    Cancer Res; 2008 Mar; 68(6):1881-8. PubMed ID: 18339869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Function of Integrin-Linked Kinase in Modulating the Stemness of IL-6-Abundant Breast Cancer Cells by Regulating γ-Secretase-Mediated Notch1 Activation in Caveolae.
    Hsu EC; Kulp SK; Huang HL; Tu HJ; Salunke SB; Sullivan NJ; Sun D; Wicha MS; Shapiro CL; Chen CS
    Neoplasia; 2015 Jun; 17(6):497-508. PubMed ID: 26152358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Notch degradation system provides promise for breast cancer therapeutics.
    Liu J; Shen JX; Wen XF; Guo YX; Zhang GJ
    Crit Rev Oncol Hematol; 2016 Aug; 104():21-9. PubMed ID: 27263934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Notch pathway as candidate therapeutic target in Her2/Neu/ErbB2 receptor-negative breast tumors.
    Hirose H; Ishii H; Mimori K; Ohta D; Ohkuma M; Tsujii H; Saito T; Sekimoto M; Doki Y; Mori M
    Oncol Rep; 2010 Jan; 23(1):35-43. PubMed ID: 19956862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.